Literature DB >> 7047170

Prazosin depression of baroreflex function in hypertensive man.

E H Sasso, D T O'Connor.   

Abstract

Prazosin is a post synaptic alpha adrenergic blocker effective in hypertension, whose hypotensive effect is unaccompanied by reflex tachycardia or hyperreninemia, nor by other evidence of increased sympathetic activity. We studied the baroreceptor reflex arc as a potential mediator of these effects. Twenty-two essential hypertensive men were treated with prazosin alone versus placebo, and experienced a blood pressure fall (from 114.8 +/- 3.6 down to 101.1 +/- 2.5 mmHg, p less than 0.005) unaccompanied by any change in heart rate, plasma renin activity, or several other indices of sympathetic nervous system activity (plasma dopamine-beta-hydroxylase activity; urinary excretion of free catecholamines and vanillyl mandelic acid; all p less than 0.1). Concomitant with the blood pressure fall, there was a significant depression of baroreflex arc sensitivity, from 11.4 +/- 2.0 ms/mmHg down to 6.6 +/- 1.9 ms/mmHg (p less than 0.05), without an associated change in cardiac vagal inhibition (291.2 +/- 46.2 versus 300.3 +/- 19.2 ms, p greater than 0.1). Baroreflex arc sensitivity depression may in part explain the lack of reflex sympathetic outflow noted during prazosin treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047170     DOI: 10.1007/bf00606418

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  47 in total

1.  Urinary excretion of catecholamines and their metabolites in pheochromocytoma.

Authors:  J R CROUT; J J PISANO; A SJOERDSMA
Journal:  Am Heart J       Date:  1961-03       Impact factor: 4.749

2.  Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.

Authors:  S B Levy; J J Lilley; R P Frigon; R A Stone
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Comparative effects of prazosin and phenoxybenzamine on arterial blood pressure, heart rate, and plasma catecholamines in essential hypertension.

Authors:  J Mulvihill-Wilson; R M Graham; W Pettinger; C Muckleroy; S Anderson; F A Gaffney; C G Blomqvist
Journal:  J Cardiovasc Pharmacol       Date:  1979 Nov-Dec       Impact factor: 3.105

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  Relationship between carotid sinus pressure and plasma renin level.

Authors:  L A Brennan; A L Henninger; K E Jochim; R L Malvin
Journal:  Am J Physiol       Date:  1974-08

6.  Autonomic and non-autonomic circulatory components in essential hypertension in man.

Authors:  P I Korner; J Shaw; J B Uther; M J West; R J McRitchie; J G Richards
Journal:  Circulation       Date:  1973-07       Impact factor: 29.690

7.  Prazosin: the first-dose phenomenon.

Authors:  R M Graham; I R Thornell; J M Gain; C Bagnoli; H F Oates; G S Stokes
Journal:  Br Med J       Date:  1976-11-27

8.  Prazosin in severe in hypertension effect on blood pressure, plasma renin activity and in hypertensive emergencies.

Authors:  J M Hayes
Journal:  Med J Aust       Date:  1977-08-27       Impact factor: 7.738

9.  Neural stimulation of release of renin.

Authors:  R D Bunag; I H Page; J W McCubbin
Journal:  Circ Res       Date:  1966-10       Impact factor: 17.367

10.  Differing effects of the vasodilator drugs, prazosin and diazoxide on plasma renin activity in the dog.

Authors:  R M Graham; M R Muir; J M Hayes
Journal:  Clin Exp Pharmacol Physiol       Date:  1976 Mar-Apr       Impact factor: 2.557

View more
  7 in total

Review 1.  Heredity and the autonomic nervous system in human hypertension.

Authors:  D T O'Connor; P A Insel; M G Ziegler; V Y Hook; D W Smith; B A Hamilton; P W Taylor; R J Parmer
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

2.  Effect of UK-52,046, an alpha 1-adrenoceptor antagonist, on baroreflex function in man.

Authors:  J P McKaigue; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

3.  Pharmacokinetic and alpha 1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport.

Authors:  H Russ; B Friedgen; B Königs; C Schumacher; K H Graefe; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  Effect of indapamide on the baroreceptor reflex in essential hypertension.

Authors:  R Carretta; B Fabris; L Tonutti; G Bellini; G Battilana; A Bianchetti; L Campanacci
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  The influence of repeated administration of prazosin on its hypotensive effect and on renin release in conscious dogs. A comparison with urapidil.

Authors:  A Beck; O Kraupp; S Bacher; R Seitelberger; G Raberger
Journal:  Basic Res Cardiol       Date:  1984 Sep-Oct       Impact factor: 17.165

6.  The influence of alpha 1-adrenergic blockade on the acute antihypertensive effect of nifedipine.

Authors:  H E Sluiter; F T Huysmans; T A Thien; R A Koene
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Effect of acute and chronic oral administration of alfuzosin on baroreflex function and tremor in man.

Authors:  A H Deering; J G Riddell; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.